Svenska

Immunovia - Discover and develop tools for early diagnosis of cancers

“Pancreatic cancer is one of the most aggressive and difficult cancers to diagnose. When detected at an early stage, 5-year survival rates are greatly improved; however, currently, most diagnosed cases are in late stages. It is for this and other reasons that a test for early detection is critical. Immunovia’s IMMray™ PanCan-d has the potential of being such tool, and we are looking forward to be part of this large validation study to reveal its clinical value.”
Dr. Randall Brand, Director, GI Malignancy Early Detection, Diagnosis and Prevention Program at University of Pittsburgh.

LATEST WEBINAR
49 min


Financial reports

August 2020

Immunovia AB published the company’s Interim Report Jan-June 2020 on Thursday, August 20, 2020, at 16.00 p.m. CET.

Financial reports

Calendar

1-3 October, 2020
RCGP Annual Primary Care Conference and Exhibition – Postponed to February 2021
Place: Glasgow, UK
28-31 October, 2020
APA 2020 Annual Meeting, American Pancreatic Association
Place: Miami, FL, USA
12 November, 2020
Interim Report Jan-Sept 2020
Place: Immunovia website
All events
Subscribe

Subscribe to receive press releases and reports via email
To start your subscription you need to activate your e-mail address by clicking the link in the email that is sent to you after you have submitted this form. Please check the junk mail if you cannot find the message.

Press releases
Financial reports